The Utah Supreme Court reversed itself recently when it allowed a woman to sue for future damages when there's only a possibility that her breast cancer may reoccur. A previous ruling by the high court had held that patients wanting to seek future damages must do so in their initial lawsuit. It is anticipated that this latest ruling may open the door for lawsuits against physicians by patients whose diseases are in remission, according to Medical Liability Monitor (1/2006).
The Utah Supreme Court reversed itself recently when it allowed a woman to sue for future damages when there's only a possibility that her breast cancer may reoccur. A previous ruling by the high court had held that patients wanting to seek future damages must do so in their initial lawsuit. It is anticipated that this latest ruling may open the door for lawsuits against physicians by patients whose diseases are in remission, according to Medical Liability Monitor (1/2006).
This latest decision allows a breast cancer patient to sue two physicians who allegedly failed to diagnosis her disease in a timely manner. As a result of the delay, she claims that she had to undergo more aggressive treatment and could be at higher risk of recurrence for the disease. Because of the high court's reversal, it is allowing other suits that had been dismissed because of the previous ruling to be reinstated.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More